US$ 29.37
bpc-157 multiple sclerosis trial Stable gastric pentadecapeptide BPC 157 for colitis and sclerosis: Healing of cysteamine‐colitis and colon‐colon‐ anastomosis - Sikiric - 2013 - The FASEB Journal BPC-157 Peptide: Proven Research Guide
Description
Wallet Whammy: They might put a dent in your wallet, and dont hold your breath waiting for insurance to chip in

Regulatory note: BPC-157 was rescheduled to Schedule 4 (Prescription Only Medicine) in Australia from June 2024

Tesamorelin is a stabilised GHRH analogue used where a longer-acting profile is needed
Ciez, R

We also offer financing options
